Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Inflamm Bowel Dis
; 28(1): 150, 2022 Jan 05.
Article
en En
| MEDLINE
| ID: mdl-34636902
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Inflamm Bowel Dis
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2022
Tipo del documento:
Article